Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Bristol-Myers Squibb Company, 3 years.
Bristol-Myers Squibb Company
Director
Centene Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 13, 2025 | Centene Corporation | Grant or award | +3,579 | — | — |
| Dec 31, 2024 | Centene Corporation | Grant or award | +414 | — | — |
| Dec 13, 2024 | Centene Corporation | Open-market purchase | +5,000 | $58.86 | $294,300 |
| Sep 30, 2024 | Centene Corporation | Grant or award | +335 | — | — |
| Jun 30, 2024 | Centene Corporation | Grant or award | +377 | — | — |
| May 14, 2024 | Centene Corporation | Grant or award | +2,916 | — | — |
| Mar 31, 2024 | Centene Corporation | Grant or award | +324 | — | — |
| Dec 31, 2023 | Centene Corporation | Grant or award | +433 | — | — |
| Nov 20, 2023 | Bristol-Myers Squibb Company | Open-market purchase | +8,500 | $49.81 | $423,385 |
| Sep 30, 2023 | Centene Corporation | Grant or award | +470 | — | — |
| Jul 17, 2023 | Iron Mountain Incorporated (Delaware)Common Stock REIT | Grant or award | +2,264 | $0.01 | $23 |
| Jun 30, 2023 | Centene Corporation | Grant or award | +469 | — | — |
| May 10, 2023 | Centene Corporation | Grant or award | +2,947 | — | — |
| Mar 31, 2023 | Centene Corporation | Grant or award | +440 | — | — |
| Mar 22, 2023 | Centene Corporation | Inheritance | −300 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.